Statins could be linked to Parkinson's disease

A new study at the University of North Carolina indicates that statins could be linked to an increase risk of Parkinson's disease. Statins lower the level of 'bad' LDL cholesterols, which in turn was found among Parkinson's patients. Critics of the study have contended that with only 124 Parkinson's patients taking part, there wasn't enough data to confirm the link. And the researchers say they intend to test the results in a trial involving 16,000 patients. Parkinson's is characterized by the absence of dopamine-producing cells, resulting in tremors, stiffness and poor coordination.

- here's the report on the statin research

Related Articles:
Stem cell transplant a success against Parkinson's. Report
Crestor less safe than competing statins. Report

Suggested Articles

Antibiotics dubbed odilorhabdins (ODLs), inspired by soil-dwelling nematodes, hold promise for treating antibiotic-resistant infections.

A PureTech startup is developing an immune-responsive hydrogel that releases a corticosteroid into arthritic joints based on their level of inflammation.

A trial of a retinal implant built from embryonic stem cells produced encouraging results in patients with dry age-related macular degeneration.